European equities traded in the US as American depositary receipts kicked off the week on strong note late Monday morning, surging 1.83% higher to 1,442.61 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company Genfit (GNFT), which rose 6.3% and 6% respectively. They were followed by accommodations booking site trivago (TRVG) and financial services company ING Groep (ING), which increased 5.6% and 5.3% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion Biotech (EVAX), which dropped 8.5% and 6.7% respectively. They were followed by internet browser company Opera (OPRA) and semiconductor company Sequans Communications (SQNS), which were down 2% and 1.7% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which advanced 6.3% and 3.7% respectively. They were followed by biopharmaceutical company TC Biopharm (TCBP) and mining company BHP Group (BHP), which were up 3.6% and 3.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Bicycle Therapeutics (BCYC), which fell 4% and 2.4% respectively. They were followed by biopharmaceutical companies NuCana (NCNA) and Verona Pharma (VRNA), which lost 2.1% and 1.6% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。